NovaBay Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
NovaBay Pharmaceuticals has a total shareholder equity of $3.3M and total debt of $1.1M, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are $9.0M and $5.7M respectively.
Key information
34.3%
Debt to equity ratio
US$1.14m
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.13m |
| Equity | US$3.31m |
| Total liabilities | US$5.72m |
| Total assets | US$9.03m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: NBY's short term assets ($7.2M) exceed its short term liabilities ($4.3M).
Long Term Liabilities: NBY's short term assets ($7.2M) exceed its long term liabilities ($1.4M).
Debt to Equity History and Analysis
Debt Level: NBY has more cash than its total debt.
Reducing Debt: NBY's debt to equity ratio has increased from 0% to 34.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NBY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NBY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.5% each year